お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
603546

患者エンゲージメントソリューションの世界市場:機会分析、市場シェアおよび予測

Global Patient Engagement Solutions Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

出版日: | 発行: Occams Business Research & Consulting Pvt. Ltd. | ページ情報: 英文 190 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.68円
患者エンゲージメントソリューションの世界市場:機会分析、市場シェアおよび予測
出版日: 2017年12月27日
発行: Occams Business Research & Consulting Pvt. Ltd.
ページ情報: 英文 190 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、患者エンゲージメントソリューションの世界市場の概要や影響因子の分析、分類、競争の展望、地域別分析、主要企業のプロファイルなどについて取り上げています。

第1章 イントロダクション

  • エグゼクティブサマリー
  • 予測手法

第2章 市場概要

  • 患者エンゲージメントソリューションの世界市場:進化と移行
  • 市場の定義と範囲
  • 産業の構造
  • 規制の枠組み
  • 市場全体の分析
    • 調査結果トップ5
    • 機会ある市場トップ5
    • トップ5企業
    • 競争戦略トップ3
  • 予測分析
  • 戦略的分析
    • 投資 vs. 導入モデル
    • 全方位的産業分析
    • ファイブフォースモデル
    • シーソー分析
    • 消費者分析と主な購入基準
  • 競争分析
    • 主な戦略と分析
    • 市場シェア分析と主な市場分析
  • 戦略的提言と主な結論
    • 地域別投資機会
    • 新興アプリケーションにおける市場機会
    • 最速成長分野における投資機会

第3章 市場の決定因子

  • 市場活性因子
  • 市場抑制因子
  • 市場機会
  • 市場の課題

第4章 市場の分類

  • コンポーネント別
    • 市場の定義と範囲
    • 意思決定支援データベースと予測手法
    • 市場分類間の比較分析
    • 市場機会のマトリクス
    • 市場分類
  • デリバリーモード別
    • 市場の定義と範囲
    • 意思決定支援データベースと予測手法
    • 市場分類間の比較分析
    • 市場機会のマトリクス
    • 市場分類
  • エンドユーザー産業別
    • 市場の定義と範囲
    • 意思決定支援データベースと予測手法
    • 市場分類間の比較分析
    • 市場機会のマトリクス
    • 市場分類
  • アプリケーション別
    • 市場の定義と範囲
    • 意思決定支援データベースと予測手法
    • 市場分類間の比較分析
    • 市場機会のマトリクス
    • 市場分類
  • 治療分野別
    • 市場の定義と範囲
    • 意思決定支援データベースと予測手法
    • 市場分類間の比較分析
    • 市場機会のマトリクス
    • 市場分類

第5章 競争展望

  • 主な戦略
    • 合併買収一覧
    • ジョイントベンチャー一覧
    • 新製品一覧
    • 提携一覧

第6章 地域別分析

  • 意思決定支援データベースと予測手法
  • 市場分類間の比較分析
  • 市場機会のマトリクス
  • 地域別分析
    • 北米
    • 欧州
    • アジア太平洋
    • その他

第7章 企業プロファイル

目次
Product Code: HHE-8911217

Patient Engagement Solutions (PES) comprises of Healthcare Information Technology (HCIT) solutions, related hardware, software and services that are generally deployed to proactively engage patients for their own health. The PES platform allows patient-focused healthcare delivery to improve health outcomes and guarantee value-based care. PES market is projected to grow at a CAGR of about 16.1% over the forecast period of 2016-2023. Some of the key drivers that boost global PES market growth includes increasing deployment of mobile health solutions and rising number of collaborations and partnerships between stakeholders. The increasing investments in Healthcare Information Technology (HCIT) solutions by stakeholders and growing popularity of patient engagement solutions among the aging population also boost global PES market growth. Some other additional PES market drivers include, health incentives that shift the burden of risk from healthcare payers to healthcare providers and implementation of government efforts and regulations to promote the patient-centric care. Some of the key growth opportunities for global PES market include, expanding medical tourism, emerging Asian economies, cloud-based models and wearable health technology. However, the global PES market growth faces a few challenges including, high implementation cost of patient engagement solutions and lack of health literacy. Moreover, global PES market growth has few restraints, such as lack of investments in infrastructure for deploying patient engagement solutions and safety of patient information from any kind of data theft or leak. Absence of interoperatibility and lack of skilled IT professionals across the healthcare industry are expected to be additional restraining factors for global PES market growth.

The global patient engagement solutions market is segmented into five key segments including, by component, delivery mode, end-user, application and therapeutic area markets. Component segment is sub-segmented into hardware, software and services. Delivery mode segment is sub-segmented into on-premise and cloud-based solutions. End-user segment is divided into patients, payers, providers and other end users. Application segment is further sub-segmented into financial health management, home health management, social and behavioral management and health management. Therapeutic area segment is further sub-segmented into fitness, chronic diseases, women's health and other therapeutic areas. Geographically, the global PES market is divided into four major regions including, North America, Asia-Pacific, Europe and Rest of World. Some of the major companies operating in the global PES market include, McKesson Corporation (U.S.), Allscripts (U.S.), IBM (U.S.), Athenahealth (U.S.), Cerner Corporation (U.S.) and others.

Table of Contents

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION & SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360-DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES & ANALYSIS
    • 2.8.2. MARKET SHARE ANALYSIS AND TOP MARKET ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. GOVERNMENT REGULATIONS AND EFFORTS TO PROMOTE PATIENT-CENTRIC CARE
    • 3.1.2. RISING INCENTIVES
    • 3.1.3. RISING ADOPTION OF PATIENT ENGAGEMENT SOLUTIONS
    • 3.1.4. NOTABLE INVESTMENTS IN HEALTHCARE INFORMATION TECHNOLOGY
    • 3.1.5. GROWING NUMBER OF STRATEGIC INITIATIVES BETWEEN STAKEHOLDERS
    • 3.1.6. RISING DEPLOYMENT OF MOBILE HEALTH SOLUTIONS
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. LACK OF INFRASTRUCTURAL INVESTMENTS
    • 3.2.2. SAFETY OF PATIENT INFORMATION
    • 3.2.3. LACK OF SKILLED IT PROFESSIONALS
    • 3.2.4. ABSENCE OF INTEROPERATIBILITY
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. RISING MEDICAL TOURISM
    • 3.3.2. EMERGING ASIAN ECONOMIES
    • 3.3.3. CLOUD-BASED MODELS
    • 3.3.4. WEARABLE HEALTH TECHNOLOGY
  • 3.4. MARKET CHALLENGES
    • 3.4.1. LACK OF HEALTH LITERACY
    • 3.4.2. HIGH IMPLEMENTATION COST

4. MARKET SEGMENTATION

  • 4.1. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY COMPONENT
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBAL HARDWARE MARKET
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.3. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.1.4. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL SOFTWARE MARKET
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.3. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.2.4. KEY CONCLUSIONS
          • 4.1.5.2.4.1. INTEGRATED SOFTWARE
          • 4.1.5.2.4.2. STANDALONE SOFTWARE
      • 4.1.5.3. GLOBAL SERVICES MARKET
        • 4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.3.3. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.3.4. KEY CONCLUSIONS
  • 4.2. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY DELIVERY MODE
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. GLOBAL ON-PREMISE SOLUTIONS MARKET
        • 4.2.5.1.1. APPLICATION
        • 4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. KEY CONCLUSIONS
      • 4.2.5.2. GLOBAL CLOUD-BASED SOLUTIONS MARKET
        • 4.2.5.2.1. APPLICATION
        • 4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. KEY CONCLUSIONS
  • 4.3. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY END-USER
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. GLOBAL PATIENTS MARKET
        • 4.3.5.1.1. APPLICATION
        • 4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. KEY CONCLUSIONS
      • 4.3.5.2. GLOBAL PAYERS MARKET
        • 4.3.5.2.1. APPLICATION
        • 4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.2.5. KEY CONCLUSIONS
      • 4.3.5.3. GLOBAL PROVIDERS MARKET
        • 4.3.5.3.1. APPLICATION
        • 4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.3.5. KEY CONCLUSIONS
      • 4.3.5.4. OTHER GLOBAL END USERS MARKET
        • 4.3.5.4.1. APPLICATION
        • 4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.4.5. KEY CONCLUSIONS
  • 4.4. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY APPLICATION
    • 4.4.1. MARKET DEFINITION AND SCOPE
    • 4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.4.4. OPPORTUNITY MATRIX
    • 4.4.5. MARKET SEGMENTATION
      • 4.4.5.1. GLOBAL FINANCIAL HEALTH MANAGEMENT MARKET
        • 4.4.5.1.1. APPLICATION
        • 4.4.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.1.5. KEY CONCLUSIONS
      • 4.4.5.2. GLOBAL SOCIAL AND BEHAVIORAL MANAGEMENT MARKET
        • 4.4.5.2.1. APPLICATION
        • 4.4.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.2.5. KEY CONCLUSIONS
      • 4.4.5.3. GLOBAL HOME HEALTH MANAGEMENT MARKET
        • 4.4.5.3.1. APPLICATION
        • 4.4.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.3.5. KEY CONCLUSIONS
      • 4.4.5.4. GLOBAL HEALTH MANAGEMENT MARKET
        • 4.4.5.4.1. APPLICATION
        • 4.4.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.4.5. KEY CONCLUSIONS
  • 4.5. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY THERAPEUTIC AREA
    • 4.5.1. MARKET DEFINITION AND SCOPE
    • 4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.5.4. OPPORTUNITY MATRIX
    • 4.5.5. MARKET SEGMENTATION
      • 4.5.5.1. GLOBAL CHRONIC DISEASES MARKET
        • 4.5.5.1.1. APPLICATION
        • 4.5.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.1.5. KEY CONCLUSIONS
        • 4.5.5.1.6. SUB-SEGMENTS
          • 4.5.5.1.6.1. OBESITY
          • 4.5.5.1.6.2. CARDIOVASCULAR DISEASES
          • 4.5.5.1.6.3. DIABETES
          • 4.5.5.1.6.4. OTHER CHRONIC DISEASES
      • 4.5.5.2. GLOBAL FITNESS MARKET
        • 4.5.5.2.1. APPLICATION
        • 4.5.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.2.5. KEY CONCLUSIONS
      • 4.5.5.3. GLOBAL WOMEN'S HEALTH MARKET
        • 4.5.5.3.1. APPLICATION
        • 4.5.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.3.5. KEY CONCLUSIONS
      • 4.5.5.4. OTHER GLOBAL THERAPEUTIC AREAS MARKET
        • 4.5.5.4.1. APPLICATION
        • 4.5.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.4.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGERS AND ACQUISITION
    • 5.1.2. LIST OF JOINT VENTURES
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIPS

6. GEOGRAPHICAL ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ALLSCRIPTS HEALTHCARE SOLUTIONS INC. (U.S.)
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. STRATEGIC INITIATIVES
    • 7.1.4. SCOT ANALYSIS
    • 7.1.5. STRATEGIC ANALYSIS
  • 7.2. ATHENAHEALTH INC. (U.S.)
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. STRATEGIC INITIATIVES
    • 7.2.4. SCOT ANALYSIS
    • 7.2.5. STRATEGIC ANALYSIS
  • 7.3. CERNER CORPORATION (U.S.)
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. STRATEGIC INITIATIVES
    • 7.3.4. SCOT ANALYSIS
    • 7.3.5. STRATEGIC ANALYSIS
  • 7.4. GETWELLNETWORK INC. (U.S.)
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. STRATEGIC INITIATIVES
    • 7.4.4. SCOT ANALYSIS
    • 7.4.5. STRATEGIC ANALYSIS
  • 7.5. IBM (U.S.)
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. STRATEGIC INITIATIVES
    • 7.5.4. SCOT ANALYSIS
    • 7.5.5. STRATEGIC ANALYSIS
  • 7.6. LINCOR SOLUTIONS LTD. (U.S.)
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. STRATEGIC INITIATIVES
    • 7.6.4. SCOT ANALYSIS
    • 7.6.5. STRATEGIC ANALYSIS
  • 7.7. MCKESSON CORPORATION (U.S.)
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. STRATEGIC INITIATIVES
    • 7.7.4. SCOT ANALYSIS
    • 7.7.5. STRATEGIC ANALYSIS
  • 7.8. MEDECISION INC. (U.S.)
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. STRATEGIC INITIATIVES
    • 7.8.4. SCOT ANALYSIS
    • 7.8.5. STRATEGIC ANALYSIS
  • 7.9. ONEVIEW HEALTHCARE (U.S.)
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. STRATEGIC INITIATIVES
    • 7.9.4. SCOT ANALYSIS
    • 7.9.5. STRATEGIC ANALYSIS
  • 7.10. ORION HEALTH LTD. (NEW ZEALAND)
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. STRATEGIC INITIATIVES
    • 7.10.4. SCOT ANALYSIS
    • 7.10.5. STRATEGIC ANALYSIS
  • 7.11. PATIENTPOINT (U.S.)
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. STRATEGIC INITIATIVES
    • 7.11.4. SCOT ANALYSIS
    • 7.11.5. STRATEGIC ANALYSIS
  • 7.12. PHYTEL INC. (U.S.)
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. STRATEGIC INITIATIVES
    • 7.12.4. SCOT ANALYSIS
    • 7.12.5. STRATEGIC ANALYSIS
  • 7.13. PLUS91
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. STRATEGIC INITIATIVES
    • 7.13.4. SCOT ANALYSIS
    • 7.13.5. STRATEGIC ANALYSIS
  • 7.14. YOURCAREUNIVERSE INC. (U.S.)
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. STRATEGIC INITIATIVES
    • 7.14.4. SCOT ANALYSIS
    • 7.14.5. STRATEGIC ANALYSIS
  • 7.15. WEIVU INC. (U.S.)
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. STRATEGIC INITIATIVES
    • 7.15.4. SCOT ANALYSIS
    • 7.15.5. STRATEGIC ANALYSIS

LIST OF TABLES

  • 1. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY COMPONENT 2014-2023 ($ MILLION)
  • 2. HARDWARE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. SOFTWARE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 4. SERVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 5. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY DELIVERY MODE 2014-2023 ($ MILLION)
  • 6. ON-PREMISE SOLUTIONS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 7. CLOUD-BASED SOLUTIONS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 8. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY END USER 2014-2023 ($ MILLION)
  • 9. PATIENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 10. PAYERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 11. PROVIDERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 12. OTHER END USERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 13. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY APPLICATION 2014-2023 ($ MILLION)
  • 14. FINANCIAL HEALTH MANAGEMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 15. SOCIAL AND BEHAVIORAL MANAGEMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 16. HOME HEALTH MANAGEMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 17. HEALTH MANAGEMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 18. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET BY THERAPEUTIC AREA 2014-2023 ($ MILLION)
  • 19. CHRONIC DISEASES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 20. FITNESS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 21. WOMEN'S HEALTH MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 22. OTHER THERAPEUTIC AREAS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 23. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 24. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 25. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 26. REST OF THE WORLD PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL HARDWARE MARKET 2014-2023 ($ MILLION)
  • 2. GLOBAL SOFTWARE MARKET 2014-2023 ($ MILLION)
  • 3. GLOBAL SERVICES MARKET 2014-2023 ($ MILLION)
  • 4. GLOBAL ON-PREMISE SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 5. GLOBAL CLOUD-BASED SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 6. GLOBAL PATIENTS MARKET 2014-2023 ($ MILLION)
  • 7. GLOBAL PAYERS MARKET 2014-2023 ($ MILLION)
  • 8. GLOBAL PROVIDERS MARKET 2014-2023 ($ MILLION)
  • 9. GLOBAL OTHER END USERS MARKET 2014-2023 ($ MILLION)
  • 10. GLOBAL FINANCIAL HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • 11. GLOBAL SOCIAL AND BEHAVIORAL MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • 12. HOME HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • 13. HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • 14. CHRONIC DISEASES MARKET 2014-2023 ($ MILLION)
  • 15. FITNESS MARKET 2014-2023 ($ MILLION)
  • 16. WOMEN'S HEALTH MARKET 2014-2023 ($ MILLION)
  • 17. OTHER THERAPEUTIC AREAS MARKET 2014-2023 ($ MILLION)
  • 18. UNITED STATES (U.S.) PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 19. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 20. UNITED KINGDOM (UK) PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 21. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 22. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 23. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 24. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 25. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 26. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 27. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 28. AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 29. ROAPAC PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 30. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
  • 31. MENA PATIENT ENGAGEMENT SOLUTIONS MARKET 2014-2023 ($ MILLION)
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.